The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Truqap Extends Radiographic Development-Free Survival in Some With Prostate Most cancers

The addition of the oral AKT inhibitor Truqap (capivasertib) to Zytiga (abiraterone acetate), prednisone and androgen deprivation remedy (ADT) prolonged investigator-assessed radiographic...

Enhertu Reduces Danger of Invasive Illness or Loss of life in HER2+ Breast Most cancers

Amongst sufferers with high-risk, HER2-positive main breast most cancers with residual invasive illness following neoadjuvant remedy, remedy with Enhertu (fam-trastuzumab deruxtecan-nxki; T-DXd)...

Tiragolumab Plus Tecentriq Doesn’t Enhance NSCLC Outcomes

Amongst sufferers domestically superior, unresectable, stage 3 non-small cell lengthy most cancers (NSCLC) that has not progressed after platinum-based concurrent chemoradiation (cCRT),...

HR+/HER2- Metastatic Breast Most cancers Development Improved With Sac-TMT

Sufferers with beforehand handled, regionally superior or metastatic hormone receptor (HR)-positive, HER2-negative breast most cancers skilled superior progression-free survival when handled with...

Presurgical Enhertu Combo Elicits Response Profit in HER2+ Early Breast Most cancers

Amongst sufferers with high-risk, HER2-positive early breast most cancers, presurgical, or neoadjuvant, remedy with Enhertu (fam-trastuzumab deruxtecan-nxki; T-DXd) adopted by paclitaxel, Herceptin...

Hot Topics